FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)
- Country
- Spain
- Type
- Beneficiary
- Website
- www.vhio.net
- Grants received
- 58
Funding record
- 58 grants on record
- €28,456,362.75 awarded in total
- 2008–2026 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
- Horizon Europe Framework Programme
- European Research Council
- Seventh Framework Programme
- Horizon 2020 Framework Programme
19 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- UNIVERSITA DEGLI STUDI DI TORINO
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
- EUROPEAN MOLECULAR BIOLOGY LABORATORY
- INSTITUT GUSTAVE ROUSSY
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Calls from this organisation
No published calls from this organisation.
Grants received
- Gold Radiosensitizers for Advanced Proton therapy
- Early clinical development of first-in-class EGL-001 targeting Tregs in head and neck squamous cell carcinoma, supported by AI-based pathomics
- Unveiling the Role of T-Lymphocyte Clonal Hematopoiesis in Antitumor Immunity to Transform Cancer Immunotherapy
- Protein-ligand data generation at scale to support computational hit finding and optimization
- Bringing MYC inhibition to the brain by ultrasound technology
- Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
- EUropean Cancer Information Portal
- Nanoengineered particles for enhanced cancer radiotherapy
- VHIO International postDoctoral programme for translAtional research
- Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS
- Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications
- Maximizing the use of a first clinically viable MYC inhibitor
- AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION
- MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT
- Drug-loaded nanobots for transmucosal delivery to mucinous tumours
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.